Publikationen

Tran, A. C., Boariu, E., García-Bengoa, M., Kim, M.-Y., Vergara, E. J., Mussá, T., & Reljic, R. (2023). Serological analysis reveals differential antibody responses between TB patients and latently infected individuals from the TB endemic country of mozambique. Frontiers in Medicine, 10, Article 1286785. https://doi.org/10.3389/fmed.2023.1286785
Details anzeigen

Victoria, C., Schulz, G., Klöhn, M., Weber, S., Holicki, C. M., Brüggemann, Y., Becker, M., Gerold, G., Eiden, M., Groschup, M. H., Steinmann, E., & Kirschning, A. (2023). Halogenated Rocaglate Derivatives: pan-antiviral agents against Hepatitis E Virus and Emerging Viruses. Journal of Medicinal Chemistry, 67(1), 289–321. https://doi.org/10.1021/acs.jmedchem.3c01357
Details anzeigen

Wilken, L. (2023). Novel interventions against mosquito-borne flaviviruses. https://nbn-resolving.org/urn:nbn:de:gbv:95-119213
Details anzeigen

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
Details anzeigen

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
Details anzeigen

Wohlsein, J. C., Meurer, M., Mörgelin, M., Neßler, J., Flegel, T., Schenk, H., Jurina, K., Rentmeister, K., Fischer, A., Köckritz-Blickwede, M. v., & Tipold, A. (2023). Ex vivo Nachweis von NETs bei steroidresponsiver Meningitis-Arteriitis. In Tierärztliche Praxis / K (P03). Thieme. https://doi.org/10.1055/s-0043-1760773
Details anzeigen

Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbejin, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Grifoni, A., Sette, A., van de Vijver, D., Koopmans, M. P. G., et al. (2023). Imvanex vaccination induces immune responses against monkeypox virus and likely contributes to the prevention of future outbreaks. In 32nd Annual Meeting of the Society of Virology: abstracts (P 303).
Details anzeigen

Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbeijn, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Koopmans, M. P. G., Haagmans, B. L., GeurtsvanKessel, C. H., & de Vries, R. D. (2023). Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature Medicine, 29(1), 270–278. https://doi.org/10.1038/s41591-022-02090-w
Details anzeigen

de Vries, R. D., Hoschler, K., & Rimmelzwaan, G. (2023). ADCC: an underappreciated correlate of cross-protection against influenza? Frontiers in Immunology, 14, Article 1130725. https://doi.org/10.3389/fimmu.2023.1130725
Details anzeigen

van der Veldt, A. A. M., Oosting, S. F., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., Hartog, G. d., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., et al. (2023). One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment. ESMO Open: Cancer Horizons / European Society for Medical Oncology, 8(1), Article 100785. https://doi.org/10.1016/j.esmoop.2023.100785
Details anzeigen